Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
44 hedge funds and large institutions have $22.1M invested in Thorne Healthtech, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 8 closing their positions.
90% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 10
28% more capital invested
Capital invested by funds: $17.3M → $22.1M (+$4.83M)
0.04% more ownership
Funds ownership: 8.89% → 8.94% (+0.04%)
0% more funds holding
Funds holding: 44 → 44 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$591K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$308K |
| 3 |
Morgan Stanley
New York
|
+$112K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Rockefeller Capital Management
New York
|
-$298K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$279K |
| 3 |
SI
Scout Investments
Kansas City,
Missouri
|
-$222K |
| 4 |
AWS
Atria Wealth Solutions
New York
|
-$146K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$114K |
THRN Hedge Fund Activity: Q1 2023 in Review
44 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q1 2023, worth a combined $22.1M — up 28% from $17.3M a quarter earlier.
Fund positioning in THRN was balanced in Q1 2023: 8 funds opened new positions, 8 closed out, 19 added to existing stakes and 10 trimmed.
The largest buyer was Royce & Associates, opening a new position worth an estimated $591K. The largest seller was Rockefeller Capital Management, exiting entirely with an estimated $298K sold.
- 44 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $22.1M of Thorne Healthtech, Inc. Common Stock stock for Q1 2023, up 28% quarter-over-quarter.
- 8 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q1 2023 and 8 closed out, a net change of 0 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q1 2023 was Royce & Associates, an estimated $591K added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q1 2023 was Rockefeller Capital Management, an estimated $298K sold.
Based on aggregated 13F filings for Q1 2023.